IP Library Granted Patent US 7,115,409
Granted Patent B1
US 7,115,409 · App. 09/327,563 · Granted Oct 3, 2006

α-amylase mutants

Assignee: Novozymes A/S
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,115,409
App. No.
09/327,563
Granted
Oct 3, 2006
Kind
B1
Abstract

The present invention relates to a method of constructing a variant of a parent Termamyl-like α-amylase, which variant has α-amylase activity and at least one altered property as compared to the parent α-amylase, comprises i) analysing the structure of the parent Termamyl-like α-amylase to identify at least one amino acid residue or at least one structural part of the Termamyl-like α-amylase structure, which amino acid residue or structural part is believed to be of relevance for altering the property of the parent Termamyl-like α-amylase (as evaluated on the basis of structural or functional considerations), ii) constructing a Termamyl-like α-amylase variant, which as compared to the parent Termamyl-like α-amylase, has been modified in the amino acid residue or structural part identified in i) so as to alter the property, and, optionally, iii) testing the resulting Termamyl-like α-amylase variant with respect to the property in question.

Claims (6)

1. A variant of a parent α-amylase, said parent alpha-amylase having SEQ ID No. 2, in which variant the amino acid residues 325–345 of the parent α-amylase have been replaced with amino acid residues 294–313 of SEQ ID No. 10.

2. A variant of a parent Bacillus alpha-amylase, wherein said parent has the amino acid sequence shown in SEQ ID NO:2, 4, or 6, said variant having an amino acid sequence which differs from the amino acid sequence of said parent, wherein the difference between said variant and said parent consists of a different amino acid residue in said variant than in said parent at one or more positions selected from the group consisting of the positions which correspond to amino acid residues Q298, G299, G301, L307, F343, F403, H405, D407, L427, D430, and G475 in Bacillus licheniformis alpha-amylase (SEQ ID NO:2); wherein said variant has alpha-amylase activity.

3. An alpha-amylase that is a variant of a Bacillus licheniformis alpha-amylase comprising SEQ ID NO:2, wherein Q298 is replaced with glutamic acid (E).

4. An alpha-amylase that is a variant of a Bacillus licheniformis alpha-amylase comprising SEQ ID NO:2, wherein F343 is replaced with tryptophan (W).

5. An alpha-amylase that is a variant of a Bacillus licheniformis alpha-amylase comprising SEQ ID NO:2, wherein L427 is replaced with phenylalanine (F).

6. An alpha-amylase that is a variant of a Bacillus licheniformis alpha-amylase comprising SEQ ID NO:2, wherein L427 is replaced with tryptophan (W).

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 27, 2001
From: NOVO NORDISK A/S
To: NOVOZYMES A/S
Reel/Frame 012366/0350 →
Priority Claims (3)
DK 0128/95 · Feb 3, 1995 · national
DK 1192/95 · Oct 23, 1995 · national
DK 1256/95 · Nov 10, 1995 · national
Continuity (3)
Continuation 0868383800 · Jul 18, 1996
Continuation In Part 0860090800 · Feb 13, 1996
Continuation PCTDK960005700 · Feb 5, 1996